Author | Yoshinobu Kubota, MD, PhD

Articles

UFT in Bladder Cancer

July 01, 1999

UFT, a compound containing uracil and tegafur (a prodrug of 5-fluorouracil) in a 4:1 molar ratio, has been used in Japan for the treatment of and as adjuvant chemotherapy for bladder cancer. In phase II studies, 300 to 600